Corbus Pharmaceuticals Holdings Inc. Stock Rises 4.4%, Outperforms Peers

Dow Jones
08/08

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. rallied 4.4% to $10.17 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.3% to 26,690.62 and the Dow Jones Industrial Average rising 0.3% to 54,036.93.

This was the stock's fourth consecutive day of gains.

Corbus Pharmaceuticals Holdings Inc. closed 50.5% short of its 52-week high of $20.56, which the company reached on October 20th.

The stock outperformed some of its peers, as Vanda Pharmaceuticals Inc. fell 2.2% to $5.00, Fortress Biotech Inc. fell 3.6% to $2.67, and Viking Therapeutics Inc. rose 2.88% to $34.26.

Trading volume totaled 352,885, compared to the 50-day average of 447,114.

Data source: Dow Jones Market Data, FactSet

 

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10